Septal Mapping And Resynchronisation Therapy- (SMART) Study

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

August 5, 2021

Study Completion Date

August 23, 2022

Conditions
Cardiac Resynchronization TherapyHeart Failure
Interventions
DEVICE

Cardiac resynchronization therapy by CRT-P or CRT-D implantation

Clinically indicated implantation of a CRT-P or CRT-D device as per standard of care

Trial Locations (1)

2113

Abbott Medical Australia Pty Ltd, Macquarie Park

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT04595305 - Septal Mapping And Resynchronisation Therapy- (SMART) Study | Biotech Hunter | Biotech Hunter